Keyphrases
Disease Progression
100%
Genetic Variants
100%
DNA Repair Pathways
100%
Multiple Myeloma Patients
100%
Non-associated
100%
Nucleotide Excision Repair
80%
Base Excision Repair Pathway
60%
Autologous Transplantation
40%
Single nucleotide Polymorphism
40%
DNA Damage
20%
Path Analysis
20%
Common Variation
20%
High-dose Melphalan
20%
Medicine and Dentistry
Disease Exacerbation
100%
Multiple Myeloma
100%
DNA Repair
100%
Genetic Variability
100%
Base Excision Repair
100%
Autotransplantation
28%
Single Nucleotide Polymorphism
28%
Drug Megadose
14%
DNA Damage
14%
Melphalan
14%
Immunology and Microbiology
Excision Repair
100%
Genetic Variability
100%
Multiple Myeloma
100%
DNA Repair
100%
Single Nucleotide Polymorphism
28%
Autotransplantation
28%
Drug Megadose
14%
DNA Damage
14%
Biochemistry, Genetics and Molecular Biology
Genetic Divergence
100%
DNA Repair
100%
Base Excision Repair
100%
Nucleotide Excision Repair
57%
Single-Nucleotide Polymorphism
28%
Autotransplantation
28%
DNA Damage
14%
Drug Megadose
14%
Melphalan
14%
Neuroscience
DNA Repair
100%
Base Excision Repair
100%
Nucleotide Excision Repair
57%
Single-Nucleotide Polymorphism
28%
Melphalan
14%
DNA Damage
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Exacerbation
100%
Multiple Myeloma
100%
Base
60%
Melphalan
20%